🇺🇸 FDA
Patent

US 11512078

Addition salt of S1P1 receptor agonist and crystal form thereof, and pharmaceutical composition

granted A61PA61P37/06

Quick answer

US patent 11512078 (Addition salt of S1P1 receptor agonist and crystal form thereof, and pharmaceutical composition) held by SuZhou Connect Biopharmaceuticals, Inc. expires Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SuZhou Connect Biopharmaceuticals, Inc.
Grant date
Tue Nov 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61P, A61P37/06